Who has approved the new HIV drug, now only twice a year dose, know how it will work
HIV and the treatment model so far
Friends, till now the treatment of HIV mostly depended on antiretroviral therapy. The patient had to take one or more pills every day whose strict routine had to be followed. If one missed the routine, the virus could become active again. Or the routine was very demanding and many people were not able to follow it regularly. Due to this, many times the virus became resistant and the treatment also failed. Apart from this, friends taking medicine every day also had a psychological impact. The patient felt that he would never be able to get rid of HIV. In the midst of all this, friends, there was a need for such a therapy that is frequent, effective and patient friendly. Keeping this demand in mind, a new long acting injection therapy has been approved.
It can also be useful for prevention
Friends, Lena Cafe Video is not only for the treatment of HIV positive people but can also be used to prevent HIV. It can be used as a free exposure profit, that is, people who are at a higher risk of getting HIV can avoid the virus through this injection.
Ho believes that if this therapy reaches the global level, then there can be a significant drop in the rate of HIV. This can be a very powerful prevention method for high risk groups such as sex workers community or drug users.
What will be its ability and cast
Friends, now that the WHO has approved the drug, the next step is that every country should certify this drug through its health authority and launch it in the market. As per the initial report, the drug is available only in India and Europe on a limited scale. But friends, the most important issue for developing countries like India will be to bear its cost. The price of Vir is very high right now because it is a new technology entry. But friends, global health organizations and pharma companies are trying their best to bring this drug in a low cost version. As the production increases and demand increases, the price is also likely to decrease significantly.
If this therapy becomes affordable in India-West Indies where the number of HIV patients is in lakhs, then friends, this can bring a revolution. The government and the government will have to work on it so that this medicine can reach the ground level.
What is the long term impact of future outlook
Friends, this medicine is going to define the future of HIV treatment. When a patient has to visit the clinic once in 6 months, his quality of life improves. This also reduces the load on the health system and monitors it too. More long lasting therapies are expected to be developed in the next few years, such as implant monthly lock fillers, and more innovative drug delivery methods. The goal of HIV treatment is not just virus operation, but its completion in one day, this registration is heavy which is like a big step in a simple infection.
Conclusion
The approval of lenacafvir marks the beginning of a new era for both treatment and prevention of HIV. The injections that are required only twice a year can be a blessing for those patients who are unable to take medicines daily. This step is a strong example of health care innovation that can significantly reduce HIV cases at the global level.
Frequently Asked Questions (FAQs)
Q1. What is lenacapavir?
Lenacapavir is a long-acting HIV drug approved by WHO. It is taken only twice a year and prevents the replication of the HIV virus.
Q2. Can this drug cure HIV?
No, it is not claimed to be a complete cure for HIV. But it suppresses the virus effectively so that the patient remains healthy and the virus does not become active.
Q3. Are there any side effects?
As per clinical trials, some minor side effects like pain at the injection site, fatigue, then headache may occur. But serious side effects are rare.
Q4. Will it work for prevention too?
Yes, lenacapavir can also be used as pre-exposure prophylaxis (PrEP) for high-risk individuals.